Last $72.67 USD
Change Today +1.33 / 1.86%
Volume 9.1M
As of 8:04 PM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by MEDTRONIC INC (MDT) in the last 6 months

Announced 09/17/14
62.00M for Medtronic Xomed Instrumentation SAS And Certain Assets of Medtronic Inc.
Merger/Acquisition

Integra LifeSciences Corporation entered into a stock and asset purchase agreement to acquire Medtronic Xomed Instrumentation SAS and certain assets of Medtronic, Inc. (NYSE:MDT) for approximately $60 million in cash on September 12, 2014. The consideration is subject to a purchase price adjustment for certain working capital changes. Integra plans to fund this transaction with cash held outside the U.S. The purchase agreement contains certain termination rights allowing ...
Read More


MDT's price was unchanged after the transaction was announced on 09/17/14.
Investor / Buyer
Integra LifeSciences Corporation
Creditor / Lender
Medtronic, Inc.
 
Announced 09/4/14
Cleveland Imaging and Surgical Hospital, L.L.C.
Bankruptcy

Cleveland Imaging and Surgical Hospital, L.L.C. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Southern District of Texas on September 4, 2014. The debtor listed its assets of $12.08 million and liabilities of $18.74 million. The largest unsecured creditors include Aetna Life Insurance Company, Inc., Prexus Health, LLC, Texas Emergency Room Services, P. A., Vee Technologies USA, Texas Lithotripsy L P Viii, Medtronic, ...
Read More


MDT's price was unchanged after the transaction was announced on 09/4/14.
Creditor / Lender
Aetna Life Insurance Company, Inc.
Innovative X Ray Services LLC
Leopoldstadt, Inc.
Medtronic, Inc.
Prexus Health, LLC
Promantra Inc.
Siemens Financial Services, Inc.
Texas Emergency Room Services, P. A.
Texas Lithotripsy L P Viii
Vee Technologies USA
Financial Advisor
The Claro Group, LLC
Legal Advisor
Okin Adams & Kilmer LLP
 
Announced 08/29/14
21.00M for Acufocus, Inc.
Private Placement

Acufocus, Inc. announced that it will raise $15,695,083 in a round of funding on August 29, 2014. The company will issue common stock pursuant to exemption provided under Regulation D.


MDT's price was unchanged after the transaction was announced on 08/29/14.
Investor / Buyer
Accuitive Medical Ventures, LLC
HealthCare Royalty Partners
Medtronic, Inc.
SV Life Sciences Advisers, LLC
The Carlyle Group LP
Versant Ventures, Inc.
 
Announced 08/27/14
238.00M for N.G.C. Medical S.p.A.
Merger/Acquisition

Medtronic, Inc. (NYSE:MDT) acquired the remaining 70% stake in N.G.C. Medical S.p.A. for approximately $240 million on August 26, 2014. Post acquisition, NGC will operate as a separate entity and will serve as the Managed Services arm for Medtronic's Hospital Solutions business. Medtronic expects the net impact from this transaction to be neutral to fiscal year 2015 earnings. Paola Sangiovanni of Italy Legal Focus acted aas legal advisor for Medtronic. Luigi Croce of ...
Read More


MDT's price was unchanged after the transaction was announced on 08/27/14.
Investor / Buyer
Medtronic, Inc.
 
Announced 08/25/14
200.00M for Sapiens Steering Brain Stimulation GmbH
Merger/Acquisition

Medtronic, Inc. (NYSE:MDT) acquired Sapiens Steering Brain Stimulation from BioDiscovery 3, FCPR managed by Edmond de Rothschild Investment Partners, S.A.S., Life Sciences Partners BV, INKEF Capital, Wellington Ventures, Wellcome Trust, Investment Division and Gilde Healthcare III managed by Gilde Healthcare Partners B.V. for approximately $200 million in cash on August 25, 2014. The group of sellers includes Wellington Ventures, Wellcome Trust, Investment Division, ...
Read More


MDT's price was unchanged after the transaction was announced on 08/25/14.
Investor / Buyer
Medtronic, Inc.
Creditor / Lender
BioDiscovery 3, FCPR
Edmond de Rothschild Investment Partners, S.A.S.
Gilde Healthcare III
Gilde Healthcare Partners B.V.
INKEF Capital
Life Sciences Partners BV
NeuroNexus Technologies, Inc.
NL Agency
Wellcome Trust, Investment Division
Wellington Ventures
 
Announced 08/22/14
21.00M for Intrinsic Therapeutics, Inc.
Private Placement

Intrinsic Therapeutics, Inc. announced that it will receive $20,878,287 in an equity round of funding on August 22, 2014. The company will issue the securities pursuant to exemption provided under Regulation D. As of September 17, 2014, the company has received $17,256,239 from 28 investors. The transaction included participation from existing investors New Enterprise Associates, Quilvest Private Equity Ltd., and New Leaf Venture Partners. Medtronic, Inc. and Greenspring ...
Read More


MDT's price was unchanged after the transaction was announced on 08/22/14.
Investor / Buyer
Greenspring Associates, Inc.
Medtronic, Inc.
New Enterprise Associates
New Leaf Venture Partners
Quilvest Private Equity Ltd.
 
Announced 07/28/14
99.00M for Visualase, Inc.
Merger/Acquisition

Medtronic, Inc. (NYSE:MDT) acquired 91.43% stake in Visualase, Inc. for $99 million from Eventi Capital Partners on July 28, 2014. The transaction includes an initial payment of $64 million plus additional payments of up to $35 million which are contingent upon Visualase achievement of specific milestones. Medtronic expects the net impact from the transaction to be neutral to fiscal year 2015 earnings and accretive thereafter. Leerink Partners LLC acted as the financial ...
Read More


MDT's price was unchanged after the transaction was announced on 07/28/14.
Investor / Buyer
Medtronic, Inc.
Creditor / Lender
Eventi Capital Partners
Financial Advisor
Leerink Partners LLC
Legal Advisor
Miller, Egan, Molter & Nelson LLP
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $72.67 USD +1.33

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergan Inc/United States $208.03 USD +2.28
Astellas Pharma Inc ¥1,655 JPY +1.50
Becton Dickinson and Co $136.80 USD +2.76
Fresenius SE & Co KGaA €42.04 EUR -0.038
Stryker Corp $92.83 USD +2.05
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 24.9x
Price/Sales 4.1x
Price/Book 3.6x
Price/Cash Flow 21.7x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.